While bile acids are not mutagenic, they have been shown to act as tumour promoters in animal studies (Narisawa et al, 1974; Mahmoud et al, 1999) and PKC has been identified as their molecular target (Pongracz et al, 1995). This evidence concerns the gene PRRT2 and neoplasm.